Amulet Capital Partners installed Adam Grossman as partner, entrusting him with sourcing and structuring platforms that sharpen healthcare services. Amulet Capital now leans on his record of aligning capital with operators who demand discipline and speed. He will press management teams to expand reach while containing cost, targeting durable cash flows in a sector craving predictability amid pricing pressure.

Grossman arrives after steering healthcare services and technology-enabled bets at Deerfield Management, where deal teams chased integration upside and margin lift. Before that, he shaped growth as senior vice president of corporate development and operations at The Advisory Board Company, translating strategy into operating leverage. These roles forged his bias for platforms that marry data rigor with frontline execution.

His mandate tightens Amulet’s focus on roll-ups that consolidate fragmented care delivery and back-office functions. By stressing unit economics over vanity metrics, the firm seeks to build platforms that trade on reliability rather than hype. Grossman now anchors a strategy built on control and continuity rather than financial engineering.